Filing Flows › 8-K events › Volitionrx
Volitionrx: entry into a material definitive agreement
Form 8-K filed Oct 27, 2026 · items 1.01, 8.01
Entry into a material definitive agreementVolitionRx Limited Announces $500,000 Partial Pre-Payment of Convertible Note in Cash
What the filing says
As previously reported, VolitionRx Limited (the “ Company ”) and Lind Global Asset Management XII LLC (“ Lind ”) entered into a Securities Purchase Agreement, dated May 15, 2025, as amended and restated on January 7, 2026, pursuant to which the Company issued and sold to Lind in addition to certain common stock purchas
Read the filing on SEC EDGAR →
What usually followsAcross 23,525 8-Ks reporting Item 1.01 (material definitive agreement) in our universe, the stock's median move the next session was 0.0% (typical size ±1.4%, up 51% of the time); over the following 21 sessions, +1.0%. Item 8.01: +0.1% next session across 44,881. Every item ranked →
What this kind of filing means
Item 1.01 — Entry into a material definitive agreement. A material agreement is one the company considers important enough to disclose within four business days: a merger agreement, a large supply or customer contract, a credit agreement or a licence. The terms often move the company’s outlook more than a quarter’s results.
Volitionrx at a glance
Volitionrx, Q2 2026: revenue $399K (-2% year over year). The chart follows the revenue to costs, profit and cash.
Volitionrx: every quarter, Q/Q and Y/Y, holders and guidance →
Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.